SHR-3167

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SHR-3167, covering 2025-11-18 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes [Phase 1]

See pricing